Clinical Trials

    A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

    Investigator: Juan Toledo Atucha

    Study Coordinator: Jorge Rodriguez Gaytan

    Status: Enrolling

    ClinicalTrials.gov Number: NCT05531656

    Phone: 346.238.2677

    Protocol Number: PRO00038185

    Description


    This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease